@NRxPharma
(NASDAQ: NRXP) has re-filed its Abbreviated New Drug Application (ANDA) for KETAFREE™, a preservative-free IV ketamine treatment, moving closer to expanding options for patients in need.
@vincemedia1
READ HERE
https://bit.ly/NRXpressrelease
Watch the latest
@NewToTheStreet
interview here
https://bit.ly/NTTS-NRXinterview
Learn more at https://bit.ly/NRXPharmaceuticals
#NRX #pharma #healthcare #biotechnews #innovation #businessupdate #businessnews #business #news #newtothestreet